Last updated on May 2019

A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)


Brief description of study

The purpose of this study is to assess the efficacy of ruxolitinib against best available therapy in participants with steroid-refractory chronic graft-versus-host disease (SR cGvHD).

Clinical Study Identifier: NCT03112603

Find a site near you

Start Over

Incyte Investigative Site

Tucson, AZ United States
  Connect »

Incyte Investigative Site

Duarte, CA United States
  Connect »

Incyte Investigative Site

La Jolla, CA United States
  Connect »

Incyte Investigative Site

Los Angeles, CA United States
  Connect »

Incyte Investigative Site

New Haven, CT United States
  Connect »

Incyte Investigative Site

Wilmington, DE United States
  Connect »

Incyte Investigative Site

Gainesville, FL United States
  Connect »

Incyte Investigative Site

Chicago, IL United States
  Connect »

Incyte Investigative Site

Maywood, IL United States
  Connect »

Incyte Investigative Site

Indianapolis, IN United States
  Connect »

Incyte Investigative Site

Westwood, KS United States
  Connect »

Incyte Investigative Site

Lexington, KY United States
  Connect »

Incyte Investigative Site

Boston, MA United States
  Connect »

Incyte Investigative Site

Hackensack, NJ United States
  Connect »

Incyte Investigative Site

New York, NY United States
  Connect »

Incyte Investigative Site

Chapel Hill, NC United States
  Connect »

Incyte Investigative Site

Durham, NC United States
  Connect »

Incyte Investigative Site

Winston-Salem, NC United States
  Connect »

Incyte Investigative Site

Cincinnati, OH United States
  Connect »

Incyte Investigative Site

Cleveland, OH United States
  Connect »

Incyte Investigative Site

Columbus, OH United States
  Connect »

Incyte Investigative Site

Oklahoma City, OK United States
  Connect »

Incyte Investigative Site

Philadelphia, PA United States
  Connect »

Incyte Investigative Site

Pittsburgh, PA United States
  Connect »

Incyte Investigative Site

Nashville, TN United States
  Connect »

Incyte Investigative Site

Dallas, TX United States
  Connect »

Incyte Investigative Site

Houston, TX United States
  Connect »

Incyte Investigative Site

Seattle, WA United States
  Connect »

Incyte Investigative Site

Milwaukee, WI United States
  Connect »

Novartis Investigative Site

Montpellier cedex 5, France
  Connect »

Novartis Investigative Site

Pierre-Benite Cédex, France
  Connect »

Novartis Investigative Site

Saint Priest en Jarez Cedex, France
  Connect »

Novartis Investigative Site

Vandoeuvre les Nancy cedex, France
  Connect »

Novartis Investigative Site

Pierre-Benite Cédex, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.